Skip to content

Clinical trials

Insulin Resistance trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Country / region: Singapore Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20121
20131
20141
20151
20171
20181
20192
20201
20212
20223
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting4
Unknown status3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National University of Singapore4
Institute for Human Development and Potential (IHDP), Singapore3
Singapore General Hospital3
Singapore Institute of Food and Biotechnology Innovation3
National University Health System, Singapore2
Eli Lilly and Company1
KK Women's and Children's Hospital1
Khoo Teck Puat Hospital1
Nanyang Technological University1
National University Hospital, Singapore1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance21
Diabetes Mellitus4
Obesity4
Diabetes Mellitus, Type 23
Glucose Intolerance2
Obesity, Morbid2
Prediabetic State2
Birth Weight1
Cognitive Dysfunction1
Diabetes, Gestational1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.